肝移植术后缺血型胆道病变发生危险因素分析

doi:10.3969/j.issn.1672-5069.2020.03.034

摘要/Abstract

摘要： 目的探讨肝移植术后缺血型胆道病变(ITBL)发生的危险因素。方法 2015年1月～2019年2月我院收治的接受肝移植术治疗患者312例,根据肝功能、胆道造影和影像学检查结果诊断术后ITBL的发生,采用单因素和多因素Logistic 回归分析。结果本组312例接受肝移植术患者原发疾病以原发性肝癌为主(占45.8%),术后发生ITBL者37例(11.9%);经Logistic回归分析显示输入血浆的量(OR=1.2,P=0.01)、术后1周肝动脉阻力指数(RI,OR=8.9,P=0.03)、急性排斥反应(OR=7.0,P=0.02)、冷缺血时间≥11.5 h(OR=1.1,P=0.01)为影响患者发生ITBL的独立影响因素。结论肝移植术后患者易发生ITBL,需针对诱发因素给予针对性的预防处理,以提高肝移植效果。

关键词: 肝移植术, 缺血型胆道病变, 肝动脉阻力指数, 急性排斥反应, 多因素回归分析, 危险因素 , ,

Abstract: Objective The aim of this study was to investigate the risk factors of ischemia-type biliary lesions (ITBL) in recipients of liver transplantation (LT). Methods 312 patients with terminal benign and malignant liver diseases including 143 patients (45.8%) with primary liver cancer were recruited in our hospital between January 2015 and February 2019, and the ITBL was diagnosed according to the results of liver functions, cholangiography and imaging after LT. The clinical characteristics of ITBL in patients after LT were analyzed by donor and recipient-related clinical data, and univariate and multivariate Logistic regression analysis were performed. Results Postoperative ITBL occurred in 37 cases (11.9%), and 19 (51.4%) of them belonged to extrahepatic bile duct lesions; the Logistic regression analysis showed that the amount of infusion plasma (OR=1.175, P=0.006), the 1-week resistive index of hepatic artery (OR=8.891, P=0.030), acute rejection (OR=7.022, P=0.022), and cold ischemia time ≥11.5 h (OR=1.055, P=0.014) were the independent factors led to ITBL occurrence. Conclusion The recipients of LT are prone to developing ITBL, and the clinicians should take the common induced factors into consideration and deal with appropriately in time to achieve an optimal efficacy.

Key words: Liver transplantation, Ischemia-type biliary lesions, Hepatic artery resistance index, Acute rejection, Logistic regression analysis, Risk factors

罗羽鸥,杨晓玲,李川. 肝移植术后缺血型胆道病变发生危险因素分析[J]. 实用肝脏病杂志, 2020, 23(3): 439-442.

Luo Yuou, Yang Xiaoling, Li Chuan. Risk factors of ischemia-type biliarylesions in recipients of liver transplantation[J]. Journal of Practical Hepatology, 2020, 23(3): 439-442.

参考文献

[1] Kubal C, Mangus R, Fridell J, et al. Optimization of perioperative conditions to prevent ischemic cholangiopathy in donation after circulatory death donor liver transplantation. Transplantation, 2016, 100(8): 1699-1704.
[2] Reiling J, Bridle KR, Gijbels M, et al. Low-dose lipopolysaccharide causes biliary injury by blood biliary barrier impairment in a rat hepatic ischemia/reperfusion model. Liver Transpl, 2017, 23(2): 194-206.
[3] Lattanzi B, Ott P, Rasmussen A, et al. Ischemic damage represents the main risk factor for biliary stricture after liver transplantation: A follow-up study in a danish population. In Vivo, 2018, 32(6): 1623-1628.
[4] Fonseca F, Kulkarni B, Hastak M, et al. An overview of liver transplant pathology: data from a tertiary referral centre in western india. Ann Hepatol, 2018, 17(3): 426-436.
[5] 李伟, 王瑞星, 韩久付, 等. 腹部CT和EUS检查慢性胰腺炎患者表现特点及其诊断价值分析. 实用肝脏病杂志, 2018, 21(5): 785-788.
[6] Hong SY, Hu XG, Lee HY, et al. Longterm analysis of biliary complications after duct-to-duct biliary reconstruction in living donor liver transplantations. Liver Transpl, 2018, 24(8): 1050-1061.
[7] Ruiz de Azúa-López Z, Naranjo-Izurieta JR, Lameirao J, et al. Cold ischemia time as a factor in post-transplantation complications for orthotopic hepatic transplantation. Transplant Proc, 2018, 50(2): 637-639.
[8] 傅斌生, 易述红, 唐晖, 等.公民逝世后器官捐献肝移植术后胆道并发症供者相关危险因素分析.中华肝脏外科手术学电子杂志, 2016, 5(4): 235-239.
[9] van Rijn R, van Leeuwen OB, Matton APM, et al. Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers. Liver Transpl, 2018, 24(5): 655-664.
[10] 丁蕾, 张振, 刘福全. 实时超声弹性成像技术对原位肝移植患者术后缺血型胆道病变临床评估价值分析. 实用肝脏病杂志, 2018, 21(6): 963-966.
[11] Zhang J, Ren FG, Liu P, et al. Characteristics of fecal microbial communities in patients with non-anastomotic biliary strictures after liver transplantation. World J Gastroenterol, 2017, 23(46): 8217-8226.
[12] Montalti R, Benedetti Cacciaguerra A, Nicolini D, et al. Impact of aberrant left hepatic artery ligation on the outcome of liver transplantation. Liver Transpl, 2018, 24(2): 204-213.
[13] Patrono D, Lavezzo B, Molinaro L, et al. Hypothermic oxygenated machine perfusion for liver transplantation: An initial experience. Exp Clin Transplant, 2018, 16(2): 172-176.
[14] 王正昕,钦伦秀. 肝移植术后并发症的防治现状及进展. 中国普外基础与临床杂志,2018,25(09):1025-1030.
[15] 林诗彬, 郑恩海, 杨克丰, 等. 彩色多普勒超声检查对乙型肝炎肝硬化患者食管静脉曲张预测价值分析. 实用肝脏病杂志, 2019,22(3): 409-412.
[16] Baker TB, Zimmerman MA, Goodrich NP, et al. Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. Liver Transpl, 2017, 23(12): 1519-1530.
[17] Jiang T, Li C, Duan B, et al. Risk factors for and management of ischemic-type biliary lesions following orthotopic liver transplantation: A single center experience. Ann Hepatol, 2016, 15(1): 41-46.
[18] Fujiki M, Hashimoto K, Palaios E, et al. Probability, management, and long-term outcomes of biliary complications after hepatic artery thrombosis in liver transplant recipients. Surgery, 2017, 162(5): 1101-1111.
[19] Junger HH, Schlitt HJ, Geissler EK, et al. Bile duct regeneration and immune response by passenger lymphocytes signals biliary recovery versus complications after liver transplantation. Liver Transpl, 2017, 23(11): 1422-1432.
[20] Bohorquez H, Seal JB, Cohen AJ, et al. Safety and outcomes in 100 consecutive donation after circulatory death liver transplants using a protocol that includes thrombolytic therapy. Am J Transplant, 2017, 17(8): 2155-2164.
[21] Goldberg DS, Karp SJ, McCauley ME, et al. Interpreting outcomes in dcdd liver transplantation: first report of the multicenter idol consortium. Transplantation, 2017, 101(5): 1067-1073.
[22] Prieto M, Valdivieso A, Gastaca M, et al. Hepaticojejunostomy in orthotopic liver transplant: a retrospective case control study. Transplant Proc, 2019, 51(1): 58-61.
[23] 赵宇, 祝瑜, 张代忠. 人脐带间充质干细胞肝内移植联合苦参素治疗失代偿期乙型肝炎肝硬化患者疗效与转归分析. 实用肝脏病杂志, 2018, 21(3): 360-363.
[24] Hessheimer AJ, Vendrell M, Muoz J, et al. Heparin but not tissue plasminogen activator improves outcomes in donation after circulatory death liver transplantation in a porcine model. Liver Transpl, 2018, 24(5): 665-676.
a) Dominguez Bastante M, Molina Raya A, Vilchez Rabelo A, et al. Analysis of ischemic cholangiopathy after treatment of arterial thrombosis in liver transplantation in our series. Transplant Proc, 2018, 50(2): 628-630.